Wellington Management Group
LRMR icon

Wellington Management Group’s Larimar Therapeutics LRMR Stock Holding History

Wellington Management Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-136,530
Closed -$614K – 2011
2026
Q1 		$614K Buy
+136,530
New +$546K ﹤0.01% 1749
2025
Q1 		– Sell
-116,067
Closed -$449K – 2002
2024
Q4 		$449K Buy
116,067
+10,821
+10% +$71.4K ﹤0.01% 1842
2024
Q3 		$689K Buy
105,246
+63,563
+152% +$511K ﹤0.01% 1773
2024
Q2 		$302K Buy
+41,683
New +$319K ﹤0.01% 1832
2015
Q4 		– Sell
-100,001
Closed -$38.3M – 2216
2015
Q3 		$38.3M Buy
100,001
+50,898
+104% +$22.9M 0.01% 765
2015
Q2 		$20.4M Buy
49,103
+5,503
+13% +$2.3M 0.01% 1013
2015
Q1 		$20.7M Buy
43,600
+2,029
+5% +$963K 0.01% 1028
2014
Q4 		$15.4M Buy
41,571
+1,710
+4% +$441K ﹤0.01% 1119
2014
Q3 		$9.4M Buy
+39,861
New +$9.03M ﹤0.01% 1257

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Wellington Management Group's LRMR Position: Q2 2026 in Review

Wellington Management Group sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 136,530 shares — an estimated $614K sold.

Wellington Management Group first reported a position in LRMR in Q3 2014 and held it in 9 quarters. The position peaked at $38.3M in Q3 2015. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Wellington Management Group reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Wellington Management Group sold 136,530 Larimar Therapeutics shares in Q2 2026, an estimated $614K.
  • Wellington Management Group first reported a position in Larimar Therapeutics in Q3 2014 and held it in 9 quarters.
  • Wellington Management Group's Larimar Therapeutics position peaked at $38.3M in Q3 2015.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.